FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving

A recent U.S. food additive development worth watching is the FDA’s decision to delay the effective date of two February 2026 final orders involving natural color additives: one approving beetroot red for use in human foods, and another expanding the approved uses of spirulina extract. The agency said on March 20 that the delay is pending evaluation of objections filed by interested parties. Just as importantly, the FDA also said these procedural steps do not change its determination that the color additives are safe for their intended uses. 

That makes this more than a routine regulatory pause. It shows how the U.S. color-additive market is changing in real time. On one side, the FDA is clearly trying to move more natural color options through the system. On the other, the agency is still being forced to manage the legal and procedural friction that comes with any meaningful change in food additive regulation. The story is not that natural colors are being stopped. The story is that the transition is becoming important enough to attract real scrutiny. 

The broader direction from the FDA is unmistakable. In its 2026 Human Foods Program priority deliverables, the agency said it is prioritizing a shift from petroleum-based food dyes to natural alternatives. It also said it plans to expedite review of new natural color options, complete reviews of additional natural colors, and publish draft guidance in 2026 on when fruit- and vegetable-derived juices qualify as color additives under FDA rules. 

For the food industry, this matters because color is not a cosmetic detail. It affects shelf appeal, formulation stability, brand identity and consumer perception. Replacing synthetic colors is easy to say and much harder to execute. Natural colors can behave differently in heat, light, acidity and shelf-life conditions, and manufacturers often have to rebalance cost, performance and labeling claims all at once. That is why every new approved natural color matters commercially, even when the regulatory action itself looks narrow. The market is not just asking for “cleaner” labels. It is asking for workable replacements that can survive industrial production. 

The timing also matters politically. The FDA’s 2026 agenda explicitly links food chemical review, color additive policy and broader public-health concerns, including a push to remove petroleum-based dyes from the food supply and introduce new replacements from natural sources. In that context, beetroot red and spirulina extract are not isolated ingredients. They are part of a larger reform effort in how food additives are reviewed, prioritized and discussed in public. 

So while the March 20 delay may look like a setback on paper, it is better understood as a sign that the food additive transition is entering a more serious phase. The FDA is still moving toward more natural color approvals, but it is doing so under heavier attention from regulators, industry and advocacy groups alike. That usually happens when a niche regulatory topic starts becoming a real market shift.